title: The role of caspase III inhibition in methamphetamine-induced alterations in p53 and bcl-2 expression: correlation with dopaminergic neurotoxicity.
authors.affiliation: Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079, USA.
authors.forename: Syed Z
authors.initials: SZ
authors.lastname: Imam
authors.forename: Michelle
authors.initials: M
authors.lastname: Oetinger
authors.forename: JohnT
authors.initials: J
authors.lastname: Skinner
authors.forename: W
authors.initials: W
authors.lastname: Slikker
authors.forename: Syed F
authors.initials: SF
authors.lastname: Ali
mesh_terms: D000818:Animals; D053148:Caspase 3; D061945:Caspase Inhibitors; D020169:Caspases / Q000378:metabolism*; D015259:Dopamine Agents / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects*; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D051379:Mice; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
chemical_list: D061945:Caspase Inhibitors; D015259:Dopamine Agents; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D008694:Methamphetamine; C505409:Casp3 protein, mouse; D053148:Caspase 3; D020169:Caspases